New sulphonamide-peptide hybrid molecules as potential PBP 2a ligands and methicillin resistant Staphylococcus aureus actives

References

• Abubakar, U., & Sulaiman, S. A. S. (2018). Prevalence, trend and antimicrobial susceptibility of Methicillin Resistant Staphylococcus aureus in Nigeria: a systematic review. Journal of Infection and Public Health, 11(6), 763-770. https://doi.org/10.1016/j.jiph.2018.05.013
   Google Scholar
• Appelbaum, P. C. (2006). The emergence of vancomycin-intermediate and vancomycin-resistant Staphylococcus aureus. Clinical Microbiology and Infection, 12(Suppl 1), 16–23.
   Google Scholar
• Bondock, S., Fadaly, W., & Metwally, M. A. (2010). Synthesis and antimicrobial activity of some new thiazole, thiophene and pyrazole derivatives containing benzothiazole moiety. European Journal of Medicinal Chemistry, 45(9), 3692–3701. https://doi.org/10.1016/j.ejmech.2010.05.018
   PubMed Web of Science ®Google Scholar
• Cardoso, M. H., Ribeiro, S. H., Nolasco, D. O., Fuente-Núñez, C. D. L., Felício, M. R., Gonçalves, S., Matos, C. O., Liao, L. M., Santos, N. C., Hancock, R. E. W., Franco, O. L., & Migliolo, L. (2016). A polyalanine peptide derived from polar fish with anti-infectious activities. Scientific Reports, 6, 21385. https://doi.org/10.1038/srep21385
   PubMed Web of Science ®Google Scholar
• Chang, S., Sievert, D. M., Hageman, J. C., Boulton, M. L., Tenover, F. C., Downes, F. P., Shah, S., Rudrik, J. T., Pupp, G. R., Brown, W. J., Cardo, D., & Fridkin, S. K. (2003). Infection with vancomycin-resistant Staphylococcus aureus containing the vanA resistance gene. The New England Journal of Medicine, 348(14), 1342–1347. https://doi.org/10.1056/NEJMoa025025
   PubMed Web of Science ®Google Scholar
• ChemDraw. (n.d.). ChemDraw Ultra 12.0., CambridgeSoft, Cambridge, MA. www.cambridgesoft.com
   Google Scholar
• Elliott, A. G., Huang, J. X., Neve, S., Zuegg, J., Edwards, I. A., Cain, A. K., Boinett, C. J., Barquist, L., Lundberg, C. V., Steen, J., Butler, M. S., Mobli, M., Porter, K. M., Blaskovich, M. A. T., Lociuro, S., Strandh, M., & Cooper, M. A. (2020). An amphipathic peptide with antibiotic activity against multidrug-resistant Gram-negative bacteria. Nature Communications, 11, 3184.
   PubMedGoogle Scholar
• Fishovitz, J., Hermoso, J. A., Chang, M., & Mobashery, A. (2014). Penicillin-binding protein 2a of methicillin-resistant Staphylococcus aureus. International Union of Biochemistry and Molecular Biology, 66(8), 572–577. https://doi.org/10.1002/iub.1289
   Google Scholar
• French, G. L. (2006). Bactericidal agents in the treatment of MRSA infections-the potential role of daptomycin. Journal of Antimicrobial Chemotherapy, 58(6), 1107–1117. https://doi.org/10.1093/jac/dkl393
   PubMed Web of Science ®Google Scholar
• Fuda, C., Hesek, D., Lee, M., Morio, K., Nowak, T., & Mobashery, S. (2005). Activation for catalysis of penicillin-binding protein 2a from methicillin-resistant Staphylococcus aureus by bacterial cell wall. Journal of the American Chemical Society, 127(7), 2056–2057. https://doi.org/10.1021/ja0434376
   PubMed Web of Science ®Google Scholar
• Gadad, A. K., Mahajanshetti, C. S., Nimbalkar, S., & Raichurkar, A. (2000). Synthesis and antibacterial activity of some 5-guanylhydrazone/thiocyanato-6-arylimidazo[2,1-b]-1,3, 4-thiadiazole-2-sulfonamide derivatives. European Journal of Medicinal Chemistry, 35(9), 853–857. https://doi.org/10.1016/s0223-5234(00)00166-5
   PubMed Web of Science ®Google Scholar
• Ghandi, T. N., & Malani, P. N. (2020). Combination therapy for methicillin-resistant Staphylocuccus aureus bacteremia. Journal of the American Medical Association, 323(6), 515–516.
   Web of Science ®Google Scholar
• GraphPad Prism. (n.d.). GraphPad Prism version 7.00.159 for Windows, GraphPad Software, San Diego, CA, www.graphpad.com
   Google Scholar
• Halgren, T. A. (1996). Merck molecular force field. I. Basis, form, scope, parameterization, and performance of MMFF94. Journal of Computational Chemistry, 17(5-6), 490–641. https://doi.org/10.1002/(SICI)1096-987X(199604)17:5/6<490::AID-JCC1>3.0.CO;2-P
   Web of Science ®Google Scholar
• Hernandez, P. O., Lema, S., Tyring, S. K., & Mendoza, N. (2012). Ceftaroline in complicated skin and skin-structure infections. Infection and Drug Resistance, 5, 23–35. https://doi.org/10.2147/IDR.S17432
   PubMedGoogle Scholar
• Hiramatsu, K., Hanaki, H., Ino, T., Yabuta, K., Oguri, T., & Tenover, F. C. (1997). Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. Journal of Antimicrobial Chemotherapy, 40(1), 135–136. https://doi.org/10.1093/jac/40.1.135
   PubMed Web of Science ®Google Scholar
• Ibezim, A., Nwodo, N. J., Nnaji, N. J., Ujam, O. T., Olubiyi, O. O., & Mba, C. J. (2017). In silico investigation of morpholines as novel class of trypanosomal triosephosphate isomerase inhibitors. Medicinal Chemistry Research, 26(1), 180–189. https://doi.org/10.1007/s00044-016-1739-z
   Web of Science ®Google Scholar
• Janardhanan, J., Bouley, R., Martínez-Caballero, S., Peng, Z., Batuecas-Mordillo, M., Meisel, J. E., Ding, D., Schroeder, V. A., Wolter, W. R., Mahasenan, K. V., Hermoso, J. A., Mobashery, S., & Chang, M. (2019). The quinazolinone allosteric inhibitor of PBP 2a synergizes with piperacillin and tazobactam against methicillin-resistant Staphylococcus aureus. Antimicrobial Agents and Chemotherapy, 63, e02637-18.
   PubMedGoogle Scholar
• Jevons, M. P. (1961). Celbenin – resistant Staphylococci. BMJ, 1(5219), 124–125. https://doi.org/10.1136/bmj.1.5219.124-a
   Web of Science ®Google Scholar
• Köck, R., Becker, K., Cookson, B., van Gemert-Pijnen, J. E., Harbarth, S., Kluytmans, J., Mielke, M., Peters, G., Skov, R. L., Struelens, M. J., Tacconelli, E., Navarro, A. T., Witte, W., & Friedrich, A. W. (2010). Methicillin-resistant Staphylococcus aureus (MRSA): burden of disease and control challenges in Europe. Euro Surveillance, 15(41), 19688. https://doi.org/10.2807/ese.15.41.19688-en
   PubMedGoogle Scholar
• Li, H., Leung, K.-S., Ballester, P. J., & Wong, M.-H. (2014). Istar: a web platform for large-scale protein-ligand docking. PLoS One, 9(1), e85678. https://doi.org/10.1371/journal.pone.0085678
   PubMed Web of Science ®Google Scholar
• Mohammad, H., Reddy, P. V. N., Monteleone, D., Mayhoub, A. S., Cushman, M., Hammac, G. K., & Seleem, M. N. (2015). Antibacterial characterization of novel synthetic thiazole compounds against methicillin-resistant Staphylococcus pseudintermedius. PLoS One, 10(6), e0130385. https://doi.org/10.1371/journal.pone.0130385
   PubMed Web of Science ®Google Scholar
• Molecular Operating Environment (MOE). (2014). 2014.01; Chemical Computing Group ULC, Montreal, Canada.
   Google Scholar
• Moretta, A., Scieuzo, C., Petrone, M. A., Salvia, R., Manniello, M. D., Franco, A., Lucchetti, D., Vassallo, A., Vogel, H., Sgambato, A., & Falabella, P. (2021). Antimicrobial peptides: A new hope in biomedical and pharmaceutical fields. Frontiers in Cellular and Infection Microbiology, 11, 668632. https://doi.org/10.3389/fcimb.2021.668632
   PubMed Web of Science ®Google Scholar
• Morris, G. M., Goodsell, D. S., Halliday, R. S., Huey, R., Hart, W. E., Belew, R. K., & Olson, A. J. (1998). Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function. Journal of Computational Chemistry, 19(14), 1639–1662. https://doi.org/10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B
   Web of Science ®Google Scholar
• Neelesh, K. M., Vijay, M., & Narendra, K. J. (2013). Receptor-based targeting of therapeutics. Therapeutic Delivery, 4(3), 369–394.
   PubMedGoogle Scholar
• Onoabedje, E. A., Ibezim, A., Okoro, U. C., & Batra, S. (2020). Synthesis, molecular docking, antiplasmodial and antioxidant activities of new sulfonamido-pepetide derivatives. Heliyon, 6(9), e04958. https://doi.org/10.1016/j.heliyon.2020.e04958
   PubMed Web of Science ®Google Scholar
• Onoabedje, E. A., Ibezim, A., Okoro, U. C., & Batra, S. (2021). New sulphonamide pyrolidine carboxamide derivatives: Synthesis, molecular docking, antiplasmodial and antioxidant activities. PLoS One. 16(2), e0243305. https://doi.org/10.1371/journal.pone.0243305
   PubMed Web of Science ®Google Scholar
• Oro, L., Ciani, M., & Comitini, F. (2014). Antimicrobial activity of Metschnikowia pulcherrima on wine yeasts. Journal of Applied Microbiology, 116(5), 1209–1217. https://doi.org/10.1111/jam.12446
   PubMed Web of Science ®Google Scholar
• Otero, L. H., Rojas-Altuve, A., Llarrull, L. I., Carrasco-Lopez, C., Kumarasiri, M., Lastochkin, E., Fishovitz, J., Dawley, M., Hesek, D., Lee, M., Johnson, J. W., Fisher, J. F., Chang, M., Mobashery, S., & Hermoso, J. A. (2013). How allosteric control of Staphylococcus aureus penicillin binding protein 2a enables methicillin resistance and physiological function. Proceedings of the National Academy of Sciences of the United States of America, 110(42), 16808–16813. https://doi.org/10.1073/pnas.1300118110
   PubMed Web of Science ®Google Scholar
• Ratrey, P., Mahapatra, A. D., Pandit, S., Hadianawala, M., Majhi, S., Mishra, A., & Datta, B. (2021). Emergent antibacterial activity of N-(thiazol-2-yl)benzenesulfonamides in conjunction with cell-penetrating octaarginine. RSC Advances, 11(46), 28581–28592. https://doi.org/10.1039/d1ra03882f
   PubMed Web of Science ®Google Scholar
• Sarojini, B. K., Krishna, B. G., Darshanraj, C. G., Bharath, B. R., & Manjunatha, H. (2010). Synthesis, characterization, in vitro and molecular docking studies of new 2,5-dichloro thienyl substituted thiazole derivatives for antimicrobial properties. European Journal of Medicinal Chemistry, 45(8), 3490–3496. https://doi.org/10.1016/j.ejmech.2010.03.039
   PubMed Web of Science ®Google Scholar
• Schuttelkop, A. W., & van Aalten, D. M. (2004). PRODRG : A tool for high-throughput crystallography of protein–ligand complexes. Acta Crystallographica Section D Biological Crystallography, 60(8), 1355–1712. https://doi.org/10.1107/S0907444904011679
   PubMedGoogle Scholar
• Scott, R. P., Hunenberger, P. H., Tironi, I. G., Mark, A. E., Billeter, S. R., Fennen, J., Torda, A. E., Huber, T., Krüger, P., & van Gunsteren, W. F. (1999). The GROMOS biomolecular simulation program package. The Journal of Physical Chemistry A, 103(19), 3596–3607. https://doi.org/10.1021/jp984217f
   Web of Science ®Google Scholar
• Sit, P. S., Teh, C. S., Idris, N., Sam, I. C., Omar, S. F. S., Sulaiman, H., Kong, K. L., Kamarulzaman, A., & Ponnampalavanar, S. (2017). Prevalence ofmethicillin-resistant Staphylococcus aureus (MRSA) infection and the molecu-lar characteristics of MRSA bacteraemia over a two-year period in a tertiaryteaching hospital in Malaysia. BMC Infectious Diseases, 17(274), 1–14.
   PubMedGoogle Scholar
• Solomon, S. L., & Oliver, K. B. (2014). Antibiotic resistance threats in the United States: Stepping back from the brink. American Family Physician, 89(12), 938–941.
   PubMed Web of Science ®Google Scholar
• Stryjewski, M. E., & Corey, G. R. (2014). Methicillin-Resistant Staphylococcus aureus: An Evolving Pathogen. Clinical Infectious Diseases, 58(suppl 1), S10–S19. https://doi.org/10.1093/cid/cit613
   PubMedGoogle Scholar
• Su-fang, K., Yue-tao, C., Jia-jie, C., Xuan-xian, P., Zhuanggui, C., & Hui, L. (2021). Synergy of alanine and gentamicin to reduce nitric oxide for elevating killing efficacy to antibiotic-resistant Vibrioalginolyticus. Virulence, 12(1), 1737–1753.
   PubMed Web of Science ®Google Scholar
• Tigist, A., Gizachew, Y., Ayelegn, D., & Zufan, S. (2012). Staphylococcus aureus burn wound infection among patients attending yekatit 12 hospital burn unit, Addis Ababa, Ethiopia. Ethiopian Journal of Health Sciences, 22(3), 209–213.
   PubMedGoogle Scholar
• Ugwu, D., Okoro, U. C., Ukoha, P. O., Okafor, S., Ibezim, A., & Kumar, N. M. (2017). Synthesis, characterization, molecular docking and in vitro antimalarial properties of new carboxamides bearing sulphonamide. European Journal of Medicinal Chemistry, 135, 349–369. https://doi.org/10.1016/j.ejmech.2017.04.029
   PubMed Web of Science ®Google Scholar
• Ugwuja, D. I., Okoro, U., Soman, S., Ibezim, A., Ugwu, D., Soni, R., Obi, B., Ezugwu, J., & Ekoh, O. (2021). New glycine derived peptides bearing benzenesulphonamide as an antiplasmodial agent. New Journal of Chemistry, 45(7), 3660–3674. https://doi.org/10.1039/D0NJ04387G
   Web of Science ®Google Scholar
• Verma, S. K., Verma, R., Xue, F., Thakur, P. K., Girish, Y. K., & Rakesh, K. P. (2020). Antibacterial activities of sulfonyl or sulfonamide containing heterocyclic derivatives and its structure-activity relationships (SAR) studies: A critical review. Bioorganic Chemistry, 105, 104400. https://doi.org/10.1016/j.bioorg.2020.104400
   PubMed Web of Science ®Google Scholar
• Walsh, C. (1999). Deconstructing vancomycin. Science (New York, N.Y.), 284(5413), 442–443. https://doi.org/10.1126/science.284.5413.442
   PubMed Web of Science ®Google Scholar
• Wilcox, M. H. (2005). Update on linezolid: the first oxazolidinone antibiotic. Expert Opinion on Pharmacotherapy, 6(13), 2315–2326. https://doi.org/10.1517/14656566.6.13.2315
   PubMed Web of Science ®Google Scholar
• You, J. H. S., Choi, K. W., Wong, T. Y., Ip, M., Ming, W. K., Wong, R. Y., Chan, S. N., Tse, H. T., Chau, C. T. S., & Lee, N. L. S. (2017). Disease burden, characteristics, and outcomes of methicillin-resistant staphylococcus aureus bloodstream infection in Hong Kong. Asia-Pacific Journal of Public Health, 29(5), 451–461. https://doi.org/10.1177/1010539517717365
   PubMed Web of Science ®Google Scholar